Cargando…
Recent progress in LyP-1-based strategies for targeted imaging and therapy
The identification of markers expressed by pathological cells or their microenvironment would help to distinguish such cells from the normal tissues. The strategies derived from this theory can be a promising modality for imaging and treating diseases. LyP-1, a tumor homing peptide, can selectively...
Autores principales: | Song, Ningning, Zhao, Lingzhou, Zhu, Meilin, Zhao, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442157/ https://www.ncbi.nlm.nih.gov/pubmed/30905205 http://dx.doi.org/10.1080/10717544.2019.1587047 |
Ejemplares similares
-
(99m)Tc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
por: Song, Ningning, et al.
Publicado: (2019) -
(64)Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic
Plaque
por: Seo, Jai Woong, et al.
Publicado: (2014) -
Characterization and targeting ability evaluation of cell-penetrating peptide LyP-1 modified alginate-based nanoparticles
por: Zhong, Zhirong, et al.
Publicado: (2020) -
LyP‐1‐fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells
por: Lin, Quan‐Jun, et al.
Publicado: (2020) -
Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery
por: Zhao, Lingzhou, et al.
Publicado: (2020)